Get the Stockscreener App
201.84
0.58%
+1.17
Pre-market:
201.84
Insulet Corporation stock is currently priced at $201.84, with a 24-hour trading volume of 924.58K.
It has seen a +0.58% increased in the last 24 hours and a +25.35% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $199.5 pivot point. If it approaches the $204.9 resistance level, significant changes may occur.
Previous Close:
$200.67
Open:
$200.7
24h Volume:
924.58K
Market Cap:
$14.14B
Revenue:
$1.78B
Net Income/Loss:
$234.00M
P/E Ratio:
118.04
EPS:
1.71
Net Cash Flow:
$136.70M
1W Performance:
+4.90%
1M Performance:
+25.35%
6M Performance:
-1.46%
1Y Performance:
-28.29%
1D Range:
$196.30
$204.74
52W Range:
$125.82
$298.95
Insulet Corporation Stock (PODD) Company Profile
Name
Insulet Corporation
Sector
Industry
Phone
978-600-7000
Address
600 Technology Park Drive, Suite 200, Billerica, MA
Insulet Corporation Stock (PODD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-21-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-04-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-02-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-21-23 | Upgrade | Citigroup | Neutral → Buy |
| Aug-21-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-26-23 | Initiated | Wolfe Research | Peer Perform |
| Nov-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Jul-11-22 | Downgrade | Citigroup | Buy → Neutral |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Feb-03-22 | Upgrade | BTIG Research | Neutral → Buy |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-31-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-21-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-01-21 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-19-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jan-29-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Jul-28-20 | Initiated | Wells Fargo | Overweight |
| Apr-24-20 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-03-20 | Initiated | BofA/Merrill | Neutral |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Dec-10-19 | Initiated | CFRA | Sell |
| Oct-23-19 | Initiated | Stifel | Hold |
| Oct-18-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-14-19 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-04-19 | Downgrade | UBS | Buy → Neutral |
| Oct-03-19 | Downgrade | Guggenheim | Buy → Neutral |
| Aug-06-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Jun-10-19 | Downgrade | Northland Capital | Outperform → Market Perform |
| May-06-19 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-20-18 | Initiated | Berenberg | Buy |
| Feb-22-18 | Reiterated | Barclays | Overweight |
| Jan-08-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-03-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Sep-15-17 | Initiated | Barclays | Overweight |
View All
Insulet Corporation Stock (PODD) Latest News
Parkman Healthcare Partners LLC Purchases 46,650 Shares of Insulet Co. (NASDAQ:PODD) - MarketBeat
MarketBeat
Is Insulet (PODD) Stock an Apt Pick for Your Portfolio Now? - Yahoo Finance Australia
Yahoo Finance Australia
Brown Capital Management LLC Sells 594 Shares of Insulet Co. (NASDAQ:PODD) - Defense World
Defense World
Bridgefront Capital LLC Purchases Shares of 1643 Insulet Co. (NASDAQ:PODD) - Defense World
Defense World
Insulet Co. (NASDAQ:PODD) Position Raised by State of Tennessee Treasury Department - Defense World
Defense World
Insulet Co. (NASDAQ:PODD) SVP Mark N. Field Sells 2131 Shares of Stock - Defense World
Defense World
Insulet Corporation Stock (PODD) Financials Data
Insulet Corporation (PODD) Revenue 2024
PODD reported a revenue (TTM) of $1.78 billion for the quarter ending March 31, 2024, a +30.17% rise year-over-year.
Insulet Corporation (PODD) Net Income 2024
PODD net income (TTM) was $234.00 million for the quarter ending March 31, 2024, a +38,900% increase year-over-year.
Insulet Corporation (PODD) Cash Flow 2024
PODD recorded a free cash flow (TTM) of $136.70 million for the quarter ending March 31, 2024, a +401.77% increase year-over-year.
Insulet Corporation (PODD) Earnings per Share 2024
PODD earnings per share (TTM) was $3.30 for the quarter ending March 31, 2024, a +5,400% growth year-over-year.
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod Insulin Management System (Omnipod System), which consists of an easy-to-use continuous insulin delivery system; and Personal Diabetes Manager, a handheld wireless device. It also customizes the Omnipod System technology platform for the delivery of drugs over a specified interval of time, at an administered volume. The company sells and markets its Omnipod System through a combination of direct sales representatives and independent distributors. Insulet Corporation was founded in 2000 and is headquartered in Billerica, Massachusetts.
1.94%
2.12%
Cap:
|
Volume (24h):